Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Pollastri

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Medchemcomm|February 17, 2015
EVALUATION OF AROMATIC 6-SUBSTITUTED THIENOPYRIMIDINES AS SCAFFOLDS AGAINST PARASITES THAT CAUSE TRYPANOSOMIASIS, LEISHMANIASIS, AND MALARIAJennifer L Woodring, Gautam Patel, Jessey Erath, et al.
Journal of the American Chemical Society|November 25, 2010
Neutralizing positive charges at the surface of a protein lowers its rate of amide hydrogen exchange without altering its structure or increasing its thermostabilityBryan F Shaw, Haribabu Arthanari, Max Narovlyansky, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan ParasitesWilliam Devine, Sarah M Thomas, Jessey Erath, et al.
Journal of Medicinal Chemistry|August 14, 2020
Medicinal Chemistry Optimization of a Diaminopurine Chemotype: Toward a Lead for <i>Trypanosoma brucei</i> InhibitorsBaljinder Singh, Rosario Diaz-Gonzalez, Gloria Ceballos-Perez, et al.
Plos Neglected Tropical Diseases|September 3, 2011
The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposingRosario Diaz-Gonzalez, F Matthew Kuhlmann, Cristina Galan-Rodriguez, et al.
Journal of Medicinal Chemistry|May 9, 2014
Establishment of a structure-activity relationship of 1H-imidazo[4,5-c]quinoline-based kinase inhibitor NVP-BEZ235 as a lead for African sleeping sicknessJoão D Seixas, Sandra A Luengo-Arratta, Rosario Diaz, et al.
Plos Neglected Tropical Diseases|November 27, 2018
Anilinoquinoline based inhibitors of trypanosomatid proliferationLori Ferrins, Amrita Sharma, Sarah M Thomas, et al.
International Journal of Medicinal Chemistry|December 5, 2017
Fluorinated Adenosine A<sub>2A</sub> Receptor Antagonists Inspired by Preladenant as Potential Cancer ImmunotherapeuticsGengyang Yuan, Tanner C Jankins, Christopher G Patrick, et al.
Chemical Biology & Drug Design|October 17, 2007
Efficient use of the iron ortho-nitrophenylporphyrin chloride to mimic biological oxidations of dimethylaminoantipyrineMarc J Bazin, Helen Shi, Jeannine Delaney, et al.
European Journal of Medicinal Chemistry|October 20, 2017
Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferationJennifer L Woodring, Kelly A Bachovchin, Kimberly G Brady, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Medchemcomm|February 17, 2015
EVALUATION OF AROMATIC 6-SUBSTITUTED THIENOPYRIMIDINES AS SCAFFOLDS AGAINST PARASITES THAT CAUSE TRYPANOSOMIASIS, LEISHMANIASIS, AND MALARIAJennifer L Woodring, Gautam Patel, Jessey Erath, et al.
Journal of the American Chemical Society|November 25, 2010
Neutralizing positive charges at the surface of a protein lowers its rate of amide hydrogen exchange without altering its structure or increasing its thermostabilityBryan F Shaw, Haribabu Arthanari, Max Narovlyansky, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan ParasitesWilliam Devine, Sarah M Thomas, Jessey Erath, et al.
Journal of Medicinal Chemistry|August 14, 2020
Medicinal Chemistry Optimization of a Diaminopurine Chemotype: Toward a Lead for <i>Trypanosoma brucei</i> InhibitorsBaljinder Singh, Rosario Diaz-Gonzalez, Gloria Ceballos-Perez, et al.
Plos Neglected Tropical Diseases|September 3, 2011
The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposingRosario Diaz-Gonzalez, F Matthew Kuhlmann, Cristina Galan-Rodriguez, et al.
Journal of Medicinal Chemistry|May 9, 2014
Establishment of a structure-activity relationship of 1H-imidazo[4,5-c]quinoline-based kinase inhibitor NVP-BEZ235 as a lead for African sleeping sicknessJoão D Seixas, Sandra A Luengo-Arratta, Rosario Diaz, et al.
Plos Neglected Tropical Diseases|November 27, 2018
Anilinoquinoline based inhibitors of trypanosomatid proliferationLori Ferrins, Amrita Sharma, Sarah M Thomas, et al.
International Journal of Medicinal Chemistry|December 5, 2017
Fluorinated Adenosine A<sub>2A</sub> Receptor Antagonists Inspired by Preladenant as Potential Cancer ImmunotherapeuticsGengyang Yuan, Tanner C Jankins, Christopher G Patrick, et al.
Chemical Biology & Drug Design|October 17, 2007
Efficient use of the iron ortho-nitrophenylporphyrin chloride to mimic biological oxidations of dimethylaminoantipyrineMarc J Bazin, Helen Shi, Jeannine Delaney, et al.
European Journal of Medicinal Chemistry|October 20, 2017
Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferationJennifer L Woodring, Kelly A Bachovchin, Kimberly G Brady, et al.
Pageof 7